| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |